Overview
Atrial hypertrophy refers to the thickening and enlargement of the muscular walls of the atria, often associated with conditions like hypertension, valvular heart disease, and chronic atrial fibrillation. It can lead to impaired atrial filling and potential thromboembolic events 1.Diagnosis
Echocardiography is essential for diagnosing atrial hypertrophy, assessing wall thickness, and evaluating left atrial size 1.
Electrocardiography (ECG) may show P wave changes indicative of atrial enlargement 1.
Holter monitoring or event recorders can help identify arrhythmias associated with atrial hypertrophy 1.Management
Rate control: Beta-blockers (e.g., metoprolol) or non-dihydropyridine calcium channel blockers (e.g., verapamil) for managing heart rate 1.
Anticoagulation: Warfarin or direct oral anticoagulants (DOACs) to prevent thromboembolic events in high-risk patients 1.
Lifestyle modifications: Recommended for all patients to manage underlying conditions like hypertension and obesity 1.Special Populations
Elderly: Careful monitoring of drug interactions and side effects is crucial due to polypharmacy and comorbid conditions 1.
Comorbidities: Management strategies should be tailored considering coexisting conditions such as hypertension or valvular disease 1.Key Recommendations
Use echocardiography for definitive diagnosis and monitoring of atrial hypertrophy 1 (Evidence: Strong).
Implement rate control with beta-blockers or calcium channel blockers in symptomatic patients 1 (Evidence: Strong).
Consider anticoagulation therapy based on thromboembolic risk stratification in patients with atrial hypertrophy 1 (Evidence: Moderate).References
1 Kim YH, Kwon SY, Jun EH, Choi ST, Park SJ, Kim Y. Comparison of epidural, spinal, and saddle block for holmium laser enucleation of prostate (HoLEP): A prospective randomized, comparative study. Medicine 2021. link